Serum adipokines as biomarkers of beta-cell function in patients with type 1 diabetes: Positive association with leptin and resistin and negative association with adiponectin

Diabetes/Metabolism Research and Reviews

Volumn 29, Issue 2, 2013, Pages 166-170

  Pham, Minh Nguyet ^a   Kolb, Hubert ^a   Mandrup Poulsen, Thomas ^b,c   Battelino, Tadej ^d   Ludvigsson, Johnny ^e   Pozzilli, Paolo ^f   Roden, Michael ^a,g   Schloot, Nanette C ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UNIVERSITY CHILDREN S HOSPITAL   (Slovenia)

^e LINKÖPING UNIVERSITY   (Sweden)

^f UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^g UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Adipokine; Adiponectin; C peptide; Leptin; Resistin; Type 1 diabetes

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; C PEPTIDE; GLUCOSE; HEMOGLOBIN A1C; LEPTIN; RESISTIN;

ADOLESCENT; ADULT; BODY MASS; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN SENSITIVITY; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; METABOLIC REGULATION; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL; REVIEW; TEST MEAL;

ADIPONECTIN; ADOLESCENT; ADULT; BIOLOGICAL MARKERS; BODY MASS INDEX; C-PEPTIDE; DIABETES MELLITUS, TYPE 1; FASTING; FEMALE; HUMANS; INSULIN-SECRETING CELLS; LEPTIN; MALE; MEALS; RESISTIN;

EID: 84873473154     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.2378     Document Type: Review

References (21)

1. Taube A, Schlich R, Sell H, Eckhardt K, Eckel J. Inflammation and metabolic dysfunction: links to cardiovascular diseases. Am J Physiol Heart Circ Physiol 2012; 302(11): H2148-H21465.
2. Pfleger C, Mortensen HB, Hansen L, et al. Hvidøre Study Group on Childhood Diabetes. Association of IL-1ra and adiponectin with C-peptide and remission in patients with type 1 diabetes. Diabetes 2008; 57(4): 929-937.
3. Verrijn Stuart AA, Schipper HS, Tasdelen I, et al. Altered plasma adipokine levels and in vitro adipocyte differentiation in pediatric type 1 diabetes. J Clin Endocrinol Metab 2012; 97(2): 463-472.
4. Matarese G, Sanna V, Lechler RI, et al. Leptin accelerates autoimmune diabetes in female NOD mice. Diabetes 2002; 51(5): 1356-1361.
5. Kieffer TJ, Heller RS, Habener JF. Leptin receptors expressed on pancreatic beta-cells. Biochem Biophys Res Commun 1996; 224(2): 522-527.
6. Minn AH, Patterson NB, Pack S, et al. Resistin is expressed in pancreatic islets. Biochem Biophys Res Commun 2003; 310(2): 641-645.
7. Greenbaum CJ, Mandrup-Poulsen T, McGee PF, et al. Type 1 Diabetes Trial Net Research Group; European C-Peptiderial Study Group. Mixed-meal tolerance test versus glucagon stimulation test for the assessment of beta-cell function in therapeutic trials in type 1 diabetes. Diabetes Care 2008; 31(10): 1966-1971.
8. Vila G, Riedl M, Anderwald C, et al. The relationship between insulin resistance and the cardiovascular biomarker growth differentiation factor-15 in obese patients. Clin Chem 2011; 57(2): 309-316.
9. Wijsekara N, Krishnamurthy M, Bhattachariee A, Suhail A, Sweeney G, Wheeler MB. Adiponectin-induced ERK and Akt phosphorylation protects against pancreatic beta cell apoptosis and increases insulin gene expression and secretion. J Biol Chem 2010; 285(44): 33623-33631.
10. Fasshauer M, Klein J, Neumann S, Eszlinger M, Paschke R. Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes. Biochem Biophys Res Commun 2002; 290(3): 1084-1089.
11. Forsblom C, Thomas MC, Moran J, et al. FinnDiane Study Group. Serum adiponectin concentration is a positive predictor all-cause and cardiovascular mortality in type 1 diabetes. J Intern Med 2011; 270(4): 346-355.
12. Wang MY, Chen L, Clark GO, et al. Leptin therapy in insulin-deficient type 1 diabetes. Proc Natl Acad Sci USA 2010; 107(11): 4813-4819.
13. Denroche HC, Levi J, Wideman RD, et al. Leptin therapy reverses hyperglycemia in mice with streptozotocin induced diabetes, independent of hepatic leptin signalling. Diabetes 2011; 60(5): 1414-1423.
14. Maedler K, Sergeev P, Ehses JA, et al. Leptin modulates beta cell expression of IL-1 receptor antagonist and release of IL-1 beta in human islets. Proc Natl Acad Sci USA 2004; 101(21): 8138-8143.
15. Nakata M, Okada T, Ozawaka K, Yada T. Resistin induces insulin resistance in pancreatic islets to impair glucose-induced insulin release. Biochem Biophys Res Commun 2007; 353(4): 1046-1051.
16. Brown JE, Onvango DJ, Dunmore SJ. Resistin down-regulates insulin receptor expression, and modulates cell viability in rodent pancreatic beta-cells. FEBS Lett 2007; 581(17): 3273-3276.
17. Celi F, Bini V, Papi F, et al. Circulating adipocytokines in non-diabetic and type 1 diabetic children: relationship to insulin therapy, glycaemic control and pubertal development. Diabet Med 2006; 23(17): 660-665.
18. Schäffler A, Büchler C, Müller-Ladner U, et al. Identification of variables influencing resistin serum levels in patients with type 1 and type 2 diabetes mellitus. Horm Metab Res 2004; 36(10): 702-707.
19. Esposito K, Nappo F, Giugliano F, et al. Meal modulation of circulating interleukin 18 and adiponectin concentrations in healthy subjects and in patients with type 2 diabetes mellitus. Am J Clin Nutr 2003; 78(6): 1135-1140.
20. Stirban A, Negrean M, Götting C, et al. Leptin decreases postprandially in people with type 2 diabetes, an effect reduced by the cooking method. Horm Metab Res 2008; 40(12): 896-900.
21. Yamauchi J, Osawa H, Tadasuka T, et al. Serum resistin is reduced by glucose and meal loading in healthy human subjects. Metabolism 2008; 57(2): 149-156.